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Introduction
Idiopathic CD4+ lymphocytopenia (ICL) is a rare
disorder that can predispose otherwise immunocompetent individuals to life-threatening opportunistic
infections. We present a case of a human immunodeficiency virus (HIV)-negative patient with ICL who
presented with recurrent cryptococcosis.

Case Presentation
A 39-year-old Caucasian, HIV-negative male with a past
medical history of stroke 13 years prior to admission and
an episode of cryptococcal meningitis 18 months prior
to admission presented to the hospital with generalized
weakness for 7 days. The patient had a 10 pack-year
smoking history and no significant environmental or
occupational exposures. On admission, vital signs were
significant for a temperature of 101.1oF, a heart rate of
117 beats per minute, and a blood pressure 93/75 mm
Hg. Physical exam was remarkable for an ill-appearing
male with dry mucous membranes and tachycardia.
Initial laboratory studies were significant for a white blood
count of 3.14 cells/µL (normal range = 4.5-11 cells/µL),
hemoglobin of 8.7 g/dL (normal range = 13.5-17.5 g/
dL), and creatinine of 5.2 mg/dL (normal range = 0.6-1.2
mg/dL). Blood cultures were positive for Cryptococcus
neoformans. Subsequent laboratory studies revealed a
serum cryptococcal antigen titer of 1:256 and a CD4+
count of 227 cells/μL (normal range = 410-1590 cells/
µL). The CD4+ count was 98 cells/μL when the patient
was diagnosed with cryptococcal meningitis 18 months
prior. Enzyme-linked immunosorbent assays for HIV
were negative. Anti-nuclear antibody titer was 1:80 and
anti-double stranded DNA, anti-Smith, anti-SSA, anti-SSB
, and anti-ribonucleoprotein antibodies were negative.
Lumbar puncture (LP) showed a normal opening pressure
and was negative for cryptococcal infection.
Chest X-ray revealed a right pleural mass. Subsequent
CT of the thorax revealed a 6.3 x 3.3 cm pleural-based

Figure 1: CT thorax without contrast showing a right pleural
mass (arrow).

mass in the right upper lobe of the lung (Figure 1). Due
to suspicion for a pulmonary malignancy, a Technetium
bone scan was performed and found increased uptake
in the right femur and left humerus. X-ray of the right
femur showed well-circumscribed lytic lesions in the
mid-femoral diaphysis (Figure 2). CT-guided biopsy
of the pleural mass and the femur lesion revealed
narrow-based, budding yeast that stained Gomori
methenamine silver (Figure 3a) and a capsule that
stained red with mucicarmine (Figure 3b), consistent
with a diagnosis of cryptococcosis.

Outcome and Follow-up
The patient was treated with a four-week course of
liposomal amphotericin B and flucytosine and then
discharged on fluconazole. He was also recommended
to follow up at the National Institutes of Health (NIH)
for further work-up of ICL as the predisposing etiology
of his recurrent cryptococcosis.
Two months af ter discharge, the patient was
hospitalized at an outside hospital for muscle pain and
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Figure 2: X-ray of right
femur. Lytic lesions are
shown (circled).

Figure 3a: Gomori methenamine silver (GMS) of the pleural
mass biopsy showing innumerable darkly stained yeast.

was still undergoing evaluation. He had not followed
up at the NIH yet and was still on fluconazole therapy.

Discussion
ICL is a rare disorder first defined by the US Centers
for Disease and Control in 1992 as a CD4+ count
<300 cells/mm3 or a CD4+ cell count < 20% of total
T-cells on two occasions and no serologic evidence
of HIV infection. 1 The pathogenesis of ICL remains
unclear. Researchers suggest a multifactorial etiology
from diminished T-cell precursors, increased CD4+
lymphocyte apoptosis, and genetic factors. 2,3 There
is also an association between autoimmune diseases
and ICL, most commonly Sjogren’s. However the
mechanism by which autoimmunity contributes to
ICL’s pathogenesis is ill-defined.2 Some reports suggest
IL-2 therapy may increase CD4+ counts as well as
decrease susceptibility to opportunistic infections, but
currently there are no clear strategies to increase CD4+
lymphocytes.3
The most important differential diagnosis for ICL is HIV
infection. ICL typically becomes apparent through the
manifestation of opportunistic infections, the most
prevalent of which are cryptococcosis, mycobacteriosis, and herpes zoster.4 Disseminated cryptococcosis
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Figure 3b: Mucicarmine stain of the pleural mass biopsy. Multiple
budding yeast are shown (circled).

can affect multiple organ systems including the adrenal
glands, prostate, and bones and may be mistaken for
malignancy with metastasis, 5 as was the case with our
patient. Given that meningitis is the most common
presenting illness in patients with cryptococcosis,
LP is essential even in the absence of neurological
symptoms.6,7 Untreated cryptococcal meningitis carries
a high mortality rate and can lead to cranial nerve
palsies, hearing loss, and blindness.8
According to the current Infectious Diseases Society of
America guidelines, non-HIV patients with disseminated
cryptococcosis should be treated with a four-week
course of amphotericin B and flucytosine for induction
therapy followed by maintenance therapy with
fluconazole for 6-12 months.7 However, the recommen-

dations for non-HIV patients with cryptococcosis are
often based on studies of HIV-infected patients. Given
that our patient presented with recurrent cryptococcosis in the presence of ICL, it was thought that he
should be maintained on fluconazole indefinitely.

Key Points
In summary, ICL patients can present with an array of
opportunistic infections even in the absence of HIV. The
pathogenesis of ICL remains unclear, and guidelines
on the treatment of ICL patients with opportunistic
infections are largely based on studies of HIV-infected
patients. Cryptococcosis is one of the most common
opportunistic pathogens that infect ICL patients.
Patients with cryptococcosis should have an LP even
in the absence of neurologic symptoms due to the
high morbidity and mortality of untreated cryptococcal
meningitis.
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